Total Payments
$2,728
2024 Payments
$599.69
Companies
28
Transactions
160
Medicare Patients
1,984
Medicare Billing
$178,032
Payment Breakdown by Category
Food & Beverage$2,721 (99.8%)
Education$6.64 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,721 | 159 | 99.8% |
| Education | $6.64 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $527.21 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $371.33 | 25 | $0 (2024) |
| Novo Nordisk Inc | $304.84 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $246.29 | 15 | $0 (2024) |
| Amgen Inc. | $196.51 | 12 | $0 (2024) |
| Lilly USA, LLC | $169.82 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $111.02 | 7 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $103.57 | 2 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $87.21 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $80.90 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $599.69 | 32 | AstraZeneca Pharmaceuticals LP ($168.21) |
| 2023 | $194.03 | 12 | Kowa Pharmaceuticals America, Inc. ($34.30) |
| 2022 | $612.43 | 39 | GlaxoSmithKline, LLC. ($162.46) |
| 2021 | $299.47 | 18 | Novo Nordisk Inc ($87.88) |
| 2020 | $224.44 | 14 | AstraZeneca Pharmaceuticals LP ($124.19) |
| 2019 | $427.06 | 19 | AstraZeneca Pharmaceuticals LP ($153.06) |
| 2018 | $97.24 | 7 | Janssen Pharmaceuticals, Inc ($27.14) |
| 2017 | $273.76 | 19 | Amgen Inc. ($71.63) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: VACCINE | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $14.83 | General |
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.18 | General |
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 05/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: DIABETES | ||||||
| 03/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Inflammation | ||||||
| 03/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 483 | 1,066 | $102,871 | $43,180 |
| 2022 | 7 | 416 | 891 | $78,724 | $30,871 |
| 2021 | 10 | 461 | 1,303 | $113,186 | $44,201 |
| 2020 | 11 | 624 | 1,857 | $153,893 | $59,781 |
Total Patients
1,984
Total Services
5,117
Medicare Billing
$178,032
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 177 | 646 | $48,450 | $22,521 | 46.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 64 | $14,016 | $5,566 | 39.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 64 | 134 | $12,060 | $3,520 | 29.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 52 | 55 | $8,745 | $3,163 | 36.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 60 | 68 | $6,120 | $2,420 | 39.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 44 | $5,280 | $2,384 | 45.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 34 | $4,420 | $1,922 | 43.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 21 | $3,780 | $1,685 | 44.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 151 | 522 | $39,150 | $14,308 | 36.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 63 | 78 | $12,402 | $5,521 | 44.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 71 | 145 | $9,850 | $3,717 | 37.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 64 | 68 | $5,395 | $2,488 | 46.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 23 | $5,037 | $2,117 | 42.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 29 | $3,770 | $1,410 | 37.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 26 | $3,120 | $1,311 | 42.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 157 | 675 | $50,625 | $18,386 | 36.3% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 53 | 302 | $22,650 | $9,064 | 40.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 71 | 89 | $11,570 | $4,455 | 38.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 57 | $6,840 | $2,727 | 39.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 33 | 36 | $5,724 | $2,520 | 44.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 40 | 47 | $5,875 | $2,430 | 41.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $3,942 | $1,750 | 44.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 27 | 47 | $2,350 | $1,240 | 52.8% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 17 | 18 | $2,700 | $1,149 | 42.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 14 | 14 | $910.00 | $478.40 | 52.6% |
About Dr. Chip Holbrook, MD
Dr. Chip Holbrook, MD is a Family Medicine healthcare provider based in Mendenhall, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962546192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chip Holbrook, MD has received a total of $2,728 in payments from pharmaceutical and medical device companies, with $599.69 received in 2024. These payments were reported across 160 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,721).
As a Medicare-enrolled provider, Holbrook has provided services to 1,984 Medicare beneficiaries, totaling 5,117 services with total Medicare billing of $178,032. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Mendenhall, MS
- Active Since 02/19/2007
- Last Updated 04/17/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962546192
Products in Payments
- FARXIGA (Drug) $453.67
- TRELEGY ELLIPTA (Drug) $311.63
- JARDIANCE (Drug) $211.48
- Ozempic (Drug) $195.43
- NUEDEXTA (Drug) $87.24
- ENTRESTO (Drug) $80.90
- Otezla (Drug) $79.70
- Rybelsus (Drug) $74.08
- BREZTRI (Drug) $73.54
- Prolia (Biological) $71.63
- MOUNJARO (Drug) $71.27
- VOQUEZNA (Drug) $61.86
- Yupelri (Drug) $61.00
- VERQUVO (Drug) $59.36
- VRAYLAR (Drug) $56.93
- Seglentis (Drug) $52.91
- ELIQUIS (Drug) $45.91
- ADVAIR (Drug) $39.39
- RYBELSUS (Drug) $35.33
- SEGLENTIS (Drug) $34.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mendenhall
Dr. Harpal Singh, M.d, M.D
Family Medicine — Payments: $2,137
Family Medicine $2,137
Dennis Adams, Md, MD
Family Medicine — Payments: $270.33
Family Medicine $270.33
Daniel Stevens, D.o, D.O
Family Medicine — Payments: $20.22
Family Medicine $20.22
Brenda Floyd, D.o, D.O
Family Medicine
Family Medicine